Benitec Biopharma (BNTC) Accumulated Depreciation & Amortization: 2019-2025
Historic Accumulated Depreciation & Amortization for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2025 value amounting to $14,000.
- Benitec Biopharma's Accumulated Depreciation & Amortization fell 46.15% to $14,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $66,000, marking a year-over-year decrease of 24.14%. This contributed to the annual value of $66,000 for FY2025, which is 24.14% down from last year.
- According to the latest figures from Q2 2025, Benitec Biopharma's Accumulated Depreciation & Amortization is $14,000, which was up 7.69% from $13,000 recorded in Q1 2025.
- Benitec Biopharma's Accumulated Depreciation & Amortization's 5-year high stood at $67,000 during Q1 2021, with a 5-year trough of $6,000 in Q2 2022.
- Its 3-year average for Accumulated Depreciation & Amortization is $20,600, with a median of $20,000 in 2023.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first slumped by 88.46% in 2022, then soared by 250.00% in 2023.
- Benitec Biopharma's Accumulated Depreciation & Amortization (Quarterly) stood at $55,000 in 2021, then declined by 25.45% to $41,000 in 2022, then crashed by 58.54% to $17,000 in 2023, then declined by 17.65% to $14,000 in 2024, then crashed by 46.15% to $14,000 in 2025.
- Its Accumulated Depreciation & Amortization stands at $14,000 for Q2 2025, versus $13,000 for Q1 2025 and $14,000 for Q4 2024.